MedPath

ROZLYTREK

ROZLYTREK

Approved
DIN Number

02495015

Drug Class

Human

Market Date

Mar 4, 2020

Company
HC

Hoffmann-La Roche Limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02495015
AIG Number0162010002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EX14 ENTRECTINIB
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

ENTRECTINIBActive
Strength: 200 MG
Monograph: ENTRECTINIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.